These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23288050)

  • 1. Identification of novel liver-specific mRNAs in plasma for biomarkers of drug-induced liver injury and quantitative evaluation in rats treated with various hepatotoxic compounds.
    Okubo S; Miyamoto M; Takami K; Kanki M; Ono A; Nakatsu N; Yamada H; Ohno Y; Urushidani T
    Toxicol Sci; 2013 Mar; 132(1):21-31. PubMed ID: 23288050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cell-free, liver-specific mRNAs in peripheral blood from rats with hepatotoxicity: a potential toxicological biomarker for safety evaluation.
    Miyamoto M; Yanai M; Ookubo S; Awasaki N; Takami K; Imai R
    Toxicol Sci; 2008 Dec; 106(2):538-45. PubMed ID: 18779383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury.
    Wetmore BA; Brees DJ; Singh R; Watkins PB; Andersen ME; Loy J; Thomas RS
    Hepatology; 2010 Jun; 51(6):2127-39. PubMed ID: 20235334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin and apolipoprotein H mRNAs in human plasma as potential clinical biomarkers of liver injury: analyses of plasma liver-specific mRNAs in patients with liver injury.
    Okubo S; Miyamoto M; Ito D; Takami K; Ashida K
    Biomarkers; 2016; 21(4):353-62. PubMed ID: 26901698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
    Kagawa T; Shirai Y; Oda S; Yokoi T
    Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of plasma circulating mRNA as a marker to detect hepatic injury.
    Kudo Y; Ochi T; Shimada H; Ogawa S; Shinjo K
    J Vet Med Sci; 2008 Sep; 70(9):993-5. PubMed ID: 18840978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
    Tonomura Y; Kato Y; Hanafusa H; Morikawa Y; Matsuyama K; Uehara T; Ueno M; Torii M
    J Appl Toxicol; 2015 Feb; 35(2):165-72. PubMed ID: 25186495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A performance evaluation of three drug-induced liver injury biomarkers in the rat: alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase.
    Bailey WJ; Holder D; Patel H; Devlin P; Gonzalez RJ; Hamilton V; Muniappa N; Hamlin DM; Thomas CE; Sistare FD; Glaab WE
    Toxicol Sci; 2012 Dec; 130(2):229-44. PubMed ID: 22872058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury.
    Yang X; Weng Z; Mendrick DL; Shi Q
    Toxicol Lett; 2014 Mar; 225(3):401-6. PubMed ID: 24462978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
    Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents.
    Luo L; Schomaker S; Houle C; Aubrecht J; Colangelo JL
    Toxicol Sci; 2014 Jan; 137(1):12-25. PubMed ID: 24085190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.
    Yang X; Greenhaw J; Shi Q; Su Z; Qian F; Davis K; Mendrick DL; Salminen WF
    Toxicol Sci; 2012 Feb; 125(2):335-44. PubMed ID: 22112502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
    Wang T; Fontenot RD; Soni MG; Bucci TJ; Mehendale HM
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):92-100. PubMed ID: 10896850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
    Sawant SP; Dnyanmote AV; Warbritton A; Latendresse JR; Mehendale HM
    Toxicol Appl Pharmacol; 2006 Mar; 211(3):221-32. PubMed ID: 16153671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury.
    Ijiri Y; Kato R; Sadamatsu M; Takano M; Okada Y; Tanaka K; Hayashi T
    Toxicology; 2014 Feb; 316():55-60. PubMed ID: 24389507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status.
    Clayton TA; Lindon JC; Everett JR; Charuel C; Hanton G; Le Net JL; Provost JP; Nicholson JK
    Arch Toxicol; 2004 Feb; 78(2):86-96. PubMed ID: 14520508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
    Krauskopf J; Caiment F; Claessen SM; Johnson KJ; Warner RL; Schomaker SJ; Burt DA; Aubrecht J; Kleinjans JC
    Toxicol Sci; 2015 Feb; 143(2):268-76. PubMed ID: 25359176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.
    Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective effects of reynosin against thioacetamide-induced apoptosis in primary hepatocytes and mouse liver.
    Lim S; Lee SJ; Nam KW; Kim KH; Mar W
    Arch Pharm Res; 2013 Apr; 36(4):485-94. PubMed ID: 23435943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.